Absence of Myostatin Improves Cardiac Function Following Myocardial Infarction

Area of Science:

• Cardiovascular Research
• Muscle Biology
• Regenerative Medicine

Background:

• Myostatin is known to inhibit skeletal muscle growth and regulate fibroblast proliferation.
• Its specific role in cardiac muscle and myofibroblasts following acute myocardial infarction (MI) remains less understood.
• This study investigates the impact of myostatin absence on cardiac function post-MI.

Purpose of the Study:

• To determine if the absence of myostatin affects left ventricular function after acute myocardial infarction.
• To investigate the potential protective effects of myostatin deficiency in the context of cardiac injury.

Main Methods:

• Myostatin-null (Mstn-/-) and wild-type (WT) mice underwent induced myocardial infarction (MI) via ligation of the left anterior descending artery.
• Left ventricular function was assessed at baseline, day 1, and day 28 post-MI.
• Immunohistochemistry and immunofluorescence analyzed cellular proliferation, collagen deposition, and myofibroblastic activity at day 28.

Main Results:

• Mstn-/- mice exhibited significantly improved ejection fraction recovery (61.8±1.1% vs 57.1±2.3%) and reduced collagen deposition (41.9±2.8% vs 54.7±3.4%) compared to WT mice post-MI.
• Mortality was significantly lower in Mstn-/- mice (0% vs 20%).
• No significant differences were observed in cell proliferation, cardiomyocyte apoptosis, or cardiomyocyte size between groups.

Conclusions:

• The absence of myostatin appears to offer protection to cardiac function following MI.
• Improved survival in myostatin-null mice may be attributed to a reduction in cardiac fibrosis.
• Myostatin deficiency presents a potential therapeutic avenue for mitigating adverse effects of myocardial infarction.